CP

Caribou Property

Description

Caribou Property is an investment firm.

Investor Profile

Caribou Property has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series Unknown (33%)
  • Seed (33%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Oncology
  • Biopharma
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caribou Property frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
NP
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
British Patient Capital
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 1
ALSA Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 3
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1

What are some of recent deals done by Caribou Property?

Epsilogen

London, England, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

BiopharmaBiotechnologyGeneticsLife ScienceOncologyTherapeutics
Series BMar 2, 2022
Amount Raised: $41,193,003
Macomics

Edinburgh, Edinburgh, City of, United Kingdom

Macomics is an immuno-oncology company.

BiotechnologyOncologyTherapeutics
SeedJul 29, 2021
Amount Raised: $5,920,671
Lunac Therapeutics

Leeds, Leeds, United Kingdom

Lunac Therapeutics is a UK-based drug discovery company.

BiotechnologyTherapeutics
Series UnknownMay 17, 2021
Amount Raised: $6,719,384